Contact
searchSearch
HMP Global
Login

Cognitive & Neurocognitive Disorders

Featured

quiz
Quiz
Percentage of Patients With Major or Mild Frontotemporal NCD Found With Alzheimer Disease Pathology at Autopsy
07/11/2024
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients...
07/11/2024
Psych Congress Network
An illustrated face in profile, wearing a mask
News
Cognitive Deficits Observed in Aftermath of Both Short- and Long-COVID-19
03/07/2024
Brionna Mendoza
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following...
03/07/2024
Neurology
From Neurology
Exercise Combined With Cognitive Training Could Delay Dementia Onset
News
Exercise Combined With Cognitive Training Could Delay Dementia Onset
08/09/2023
Evi Arthur
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and...
08/09/2023
Neurology
From Neurology
News
CBT Identified as Effective First-Line Treatment for Insomnia in AUD Patients
07/28/2023
Tom Valentino
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol...
07/28/2023
Addiction Professional
From Addiction Professional
quiz
Quiz
Parkinson Disease and Neurocognitive Disorder Comorbidity Rate
05/18/2023
About what percent of individuals diagnosed with Parkinson disease will eventually develop a major neurocognitive disorder (NCD), according to the DSM-5-TR? Take the quiz to find out!
About what percent of individuals diagnosed with Parkinson disease will eventually develop a major neurocognitive disorder (NCD), according to the DSM-5-TR? Take the quiz to find out!
About what percent of...
05/18/2023
Psych Congress Network
News
Women with PTSD Show Accelerated Cognitive Decline in Midlife
07/12/2022
Jolynn Tumolo
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder...
07/12/2022
Psych Congress Network
News
Healthier Diet Linked With Larger Brain Volume in Midlife
05/31/2022
Jolynn Tumolo
A higher quality diet is associated with larger brain volume during midlife, according to a study published in the Journal of Alzheimer’s Disease.
A higher quality diet is associated with larger brain volume during midlife, according to a study published in the Journal of Alzheimer’s Disease.
A higher quality diet is...
05/31/2022
Neurology
From Neurology
News
Neuropsychiatric Risk After COVID-19 On Par With Other Severe Respiratory Infections
05/25/2022
Jolynn Tumolo
Risks of new-onset neuropsychiatric disorders, such as anxiety and dementia, were similarly increased in adults surviving COVID-19 hospitalization and adults surviving hospitalization for other severe acute respiratory infections (SARI)...
Risks of new-onset neuropsychiatric disorders, such as anxiety and dementia, were similarly increased in adults surviving COVID-19 hospitalization and adults surviving hospitalization for other severe acute respiratory infections (SARI)...
Risks of new-onset...
05/25/2022
Psych Congress Network

News

An illustrated face in profile, wearing a mask
News
Cognitive Deficits Observed in Aftermath of Both Short- and Long-COVID-19
03/07/2024
Brionna Mendoza
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following COVID-19 infection, whether resolved after a short duration or longer-term persistence, have been confirmed through objective measurement.
Cognitive deficits following...
03/07/2024
Neurology
Exercise Combined With Cognitive Training Could Delay Dementia Onset
News
Exercise Combined With Cognitive Training Could Delay Dementia Onset
08/09/2023
Evi Arthur
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and computerized cognitive training could improve cognition in older adults with mild cognitive impairment, according to a randomized clinical trial published in JAMA Network Open. 
Aerobic-resistance exercise and...
08/09/2023
Neurology
News
CBT Identified as Effective First-Line Treatment for Insomnia in AUD Patients
07/28/2023
Tom Valentino
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol use disorder found cognitive behavioral therapy outperformed sleep hygiene treatment in reducing insomnia, as well as alcohol consumption, cravings, and associated negative behaviors.
A study of veterans with alcohol...
07/28/2023
Addiction Professional
News
Women with PTSD Show Accelerated Cognitive Decline in Midlife
07/12/2022
Jolynn Tumolo
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder (PTSD) was associated with accelerated cognitive decline in middle-aged women, according to a large-scale prospective cohort study.
Post-traumatic stress disorder...
07/12/2022
Psych Congress Network
News
Healthier Diet Linked With Larger Brain Volume in Midlife
05/31/2022
Jolynn Tumolo
A higher quality diet is associated with larger brain volume during midlife, according to a study published in the Journal of Alzheimer’s Disease.
A higher quality diet is associated with larger brain volume during midlife, according to a study published in the Journal of Alzheimer’s Disease.
A higher quality diet is...
05/31/2022
Neurology
News
Neuropsychiatric Risk After COVID-19 On Par With Other Severe Respiratory Infections
05/25/2022
Jolynn Tumolo
Risks of new-onset neuropsychiatric disorders, such as anxiety and dementia, were similarly increased in adults surviving COVID-19 hospitalization and adults surviving hospitalization for other severe acute respiratory infections (SARI)...
Risks of new-onset neuropsychiatric disorders, such as anxiety and dementia, were similarly increased in adults surviving COVID-19 hospitalization and adults surviving hospitalization for other severe acute respiratory infections (SARI)...
Risks of new-onset...
05/25/2022
Psych Congress Network
a young woman lies awake in bed
News
Adolescent Insomnia and Daytime Sleepiness Linked to Depression Risk
06/25/2026
Maria Mantas
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study...
06/25/2026
Psych Congress Network
A man with depression holds his head in his hands
Research Summary
Navacaprant Fails Late-Stage MDD Trials
06/22/2026
Brionna Mendoza
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid...
06/22/2026
Psych Congress Network
a man surrounded by alcohol and other substances on a table
News
Reduced Stimulant Use Outcomes May Reveal Treatment Effects Missed by Abstinence Measures
06/18/2026
Maria Mantas
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use...
06/18/2026
Psych Congress Network
Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
a woman scrolls on her phone while laying in bed
News
US Study Finds No Link Between AI Use and Depression
05/28/2026
Maria Mantas
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation...
05/28/2026
Psych Congress Network
A clinician in the lab pulls a psilocybin mushroom from a bag using tweezers major depressive disorder mdd treatment
News
Single-Dose Psilocybin Rapidly Improves MDD Symptoms, RCT Finds
05/19/2026
Brionna Mendoza
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was...
05/19/2026
Psych Congress Network
injection for schizophrenia treatment
News
Once-Monthly Aripiprazole Demonstrates Favorable Benefit–Risk Profile in Schizophrenia Treatment
05/14/2026
Maria Mantas
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg...
05/14/2026
Psych Congress Network
A man with depression holds his head in his hands
News
Lumateperone Tops Efficacy in Adjunctive Treatment for MDD, Review Finds
05/12/2026
Brionna Mendoza
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
News
The Link Between Ultra-Processed Foods and ADHD
05/12/2026
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a...
05/12/2026
Psych Congress Network

Quizzes

quiz
Quiz
Percentage of Patients With Major or Mild Frontotemporal NCD Found With Alzheimer Disease Pathology at Autopsy
07/11/2024
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients...
07/11/2024
Psych Congress Network
quiz
Quiz
Parkinson Disease and Neurocognitive Disorder Comorbidity Rate
05/18/2023
About what percent of individuals diagnosed with Parkinson disease will eventually develop a major neurocognitive disorder (NCD), according to the DSM-5-TR? Take the quiz to find out!
About what percent of individuals diagnosed with Parkinson disease will eventually develop a major neurocognitive disorder (NCD), according to the DSM-5-TR? Take the quiz to find out!
About what percent of...
05/18/2023
Psych Congress Network
Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Psilocybin Outcomes for MDD
06/11/2026
Brionna Mendoza
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
06/11/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
Nishi Bhopal, MD
Quiz
First Steps in Identifying Excessive Daytime Sleepiness
05/06/2026
Maria Mantas
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first...
05/06/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use